Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium

Resource type
Journal Article
Title
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium
Abstract
In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.
Publication
The Journal of Infectious Diseases
Date
2020-9-01
Volume
222
Issue
Suppl 3
Pages
S175-S198
Journal Abbr
J Infect Dis
Accessed
11/13/22, 4:56 PM
ISSN
0022-1899
Short Title
Core Recommendations for Antifungal Stewardship
Library Catalog
PubMed Central
Extra
PMID: 32756879 PMCID: PMC7403757
Citation
Johnson, M. D., Lewis, R. E., Dodds Ashley, E. S., Ostrosky-Zeichner, L., Zaoutis, T., Thompson, G. R., Andes, D. R., Walsh, T. J., Pappas, P. G., Cornely, O. A., Perfect, J. R., & Kontoyiannis, D. P. (2020). Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. The Journal of Infectious Diseases, 222(Suppl 3), S175–S198. https://doi.org/10.1093/infdis/jiaa394
DRUGS AND THERAPIES